Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study

Thomas Bachelot, Gilles Romieu, Mario Campone, +13

The Lancet Oncology

Breast OncologyBrain MetastasesMedicineCancer ManagementPharmacology +6

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial

Gwénaëlle Gravis, Karim Fizazi, Florence Joly, +29

The Lancet Oncology

Androgen-deprivation TherapyUrologyGenitourinary CancerMedicineGetug-afu 15 +5

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

Jean-Claude Horiot, R. Le Fur, T. Nguyen, +9

Radiotherapy and Oncology

Neuro-oncologySurgical OncologyConventional FractionationRadiation TherapyMedicine +8

Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

Martin Schlumberger, Bogdan Catargi, Isabelle Borget, +17

New England Journal of Medicine

Second primary malignancies in thyroid cancer patients

Corrado Rubino, Florent de Vathaire, Massimo E. Dottorini, +7

British Journal of Cancer

Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study

Pierre Soubeyran, Carine Bellera, Jean Goyard, +16

PLoS ONE

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients

E Modigliani, R. Cohen, José‐Marie Campos, +9

Clinical Endocrinology

Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells

Fabrice André, Nathalie Chaput, Noël E.C. Schartz, +11

The Journal of Immunology

ImmunologyCurrent Immunization ProtocolsImmunodominanceAntigen ProcessingImmune Cell Therapy +18

Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy

LM Mir, LF Glass, Gregor Serša, +16

British Journal of Cancer

NanomedicineSurgical OncologyMedicineTopical DrugTumor Targeting +5

Germline mutations in the thyrotropin receptor gene cause non–autoimmune autosomal dominant hyperthyroidism

Laurence Duprez, Jasmine Parma, Jacqueline Van Sande, +8

Nature Genetics

Autoimmune DiseaseGeneticsThyroid DiseasePathologyThyroid Disorders +6